Drug Side Effects
Search
IMMUNE-MEDIATED ENDOCRINOPATHY
IMMUNE-MEDIATED ENDOCRINOPATHY
was reported 150 times
IMMUNE-MEDIATED ENDOCRINOPATHY is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Lymphocyte Activation Gene-3 Blocker [EPC]
1
0.0019
1
Programmed Death Receptor-1 Blocking Antibody [EPC]
145
0.0015
2
CTLA-4-directed Blocking Antibody [EPC]
51
0.0011
3
Substance P/Neurokinin-1 Receptor Antagonist [EPC]
2
0.0002
4
Microtubule Inhibitor [EPC]
28
0.0002
5
Vascular Endothelial Growth Factor Inhibitor [EPC]
22
0.0001
6
Programmed Death Ligand-1 Blocker [EPC]
2
0.0001
7
Platinum-based Drug [EPC]
21
0.0001
8
Androgen [EPC]
1
0.0000
9
Provitamin D2 Compound [EPC]
1
0.0000
10
Nucleoside Metabolic Inhibitor [EPC]
4
0.0000
11
Alkylating Drug [EPC]
3
0.0000
12
Kinase Inhibitor [EPC]
5
0.0000
13
Histamine-2 Receptor Antagonist [EPC]
1
0.0000
14
Serotonin-3 Receptor Antagonist [EPC]
1
0.0000
15
Folate Analog Metabolic Inhibitor [EPC]
3
0.0000
16
Phosphodiesterase 4 Inhibitor [EPC]
1
0.0000
17
Progestin [EPC]
1
0.0000
18
Corticosteroid [EPC]
3
0.0000
19
Platelet Aggregation Inhibitor [EPC]
1
0.0000
20
Nonsteroidal Anti-inflammatory Drug [EPC]
1
0.0000